Further study is needed to investigate the impact of selective inhibition of GPC1 with anti-GPC1 mAb on the crosstalk between tumor cells and tumor-associated fibroblasts in NSCLC. The gene discussed is GPC1; the disease is non-small cell lung carcinoma.